News Digest / Lukas Schmidt

Author: Lukas Schmidt

08:11am, Thursday, Oct 10, 2024
Bernstein downgrades PayPal (NASDAQ: PYPL) to Market-Perform due to competitive pressures and growth uncertainty, though raises the price target to $80. Analysts caution about challenges in P2P transactions and potential profit revisions, advising traders to proceed cautiously.

07:46am, Thursday, Oct 10, 2024
Applied Digital (NASDAQ: APLD) reports a 67% revenue rise to $60.7M in Q1 2025, driven by data center and cloud services. However, it faced a $21.6M adjusted net loss. Strategic investments and project advancements signal potential but caution advised amid rising costs.

07:31am, Thursday, Oct 10, 2024
Tilray Brands (NASDAQ: TLRY) reported Q1 results for 2024, revealing mixed outcomes. Adjusted EPS outperformed expectations at -$0.01, but revenue fell short at $200M. Notably, beverage alcohol revenue soared 132%. Gross profit rose 35%, indicating growth potential.

07:10am, Thursday, Oct 10, 2024
Delta Air Lines (NYSE: DAL) reported Q3 earnings of $1.50 EPS, missing estimates by $0.02, with revenue at $14.59 billion. Despite a strong 41.69% annual increase, 15 negative EPS revisions raise concerns. Upcoming Q4 EPS forecast ranges from $1.60 to $1.85.

06:01am, Thursday, Oct 10, 2024
Helen of Troy (NASDAQ: HELE) reported Q2 fiscal 2025 earnings exceeding expectations, with 9% U.S. distribution growth despite a 3.5% decline in net sales. CEO Noel Geoffroy highlighted Project Pegasus and ongoing innovation efforts amidst challenges in the Beauty segment.

05:59am, Thursday, Oct 10, 2024
Byrna Technologies (NASDAQ: BYRN) reported Q3 2024 net revenues of $20.9M, up 194% YoY, driven by direct-to-consumer sales. The company reversed losses with $1M net income and plans to enhance marketing efforts. Strong growth prospects ahead.

05:55am, Thursday, Oct 10, 2024
Saratoga Investment Corp (NYSE: SAR) reports strong Q2 earnings with a 12.7% yield and a 38.3% rise in adjusted NII to $18.2M. With $385.5M in liquidity, the firm is well-positioned for growth despite recent challenges. Long-term resilience remains a focus.

05:30am, Thursday, Oct 10, 2024
CFRA Research downgraded Lululemon (NASDAQ: LULU) from Strong Buy to Hold, lowering the price target to $280 amid inventory challenges ahead of the holiday season. Despite short-term concerns and a recent revenue miss, long-term growth prospects remain positive.

05:19am, Thursday, Oct 10, 2024
Givaudan (SIX: GIVN) reported a strong Q3, featuring 14.1% organic sales growth, surpassing analysts' 10.4% forecast. Key drivers included a 12.1% volume increase and solid regional performances. UBS anticipates bullish market reactions to these results.

04:47am, Thursday, Oct 10, 2024
Greece's ExxonMobil-led consortium advances to the second phase of gas exploration near Crete, having collected 7,789 km of seismic data. This development signals strong energy investment potential, positioning ExxonMobil (NYSE: XOM) for future growth.

04:42am, Thursday, Oct 10, 2024
Google's recent Nobel wins spark debate over AI research legitimacy and regulatory scrutiny. As the tech giant faces calls for breakup, experts stress the need for public funding in tech innovation, raising crucial considerations for savvy stock investors.

04:35am, Thursday, Oct 10, 2024
Pfizer (NYSE: PFE) shares rose over 3%, outperforming the S&P 500, following news of CEO Albert Bourla’s upcoming talks with activist investor Starboard Value, which recently acquired a $1 billion stake. Investors are hopeful for strategic changes to revive the company's momentum.

04:21am, Thursday, Oct 10, 2024
Impax Asset Management is capitalizing on Nvidia's rebound, increasing its stake amid the chipmaker's promising market potential and AI-driven growth. CEO Ian Simm believes Nvidia remains undervalued despite recent gains, emphasizing its energy-efficient innovations.

04:15am, Thursday, Oct 10, 2024
Mercedes-Benz (OTC: MBGAF) reported a 1% decline in Q3 vehicle sales, driven by reduced demand in Asia. Notably, battery-electric vehicle sales fell 31%. Investors should monitor the company's strategies to adapt to luxury market shifts amidst economic uncertainties.

04:10am, Thursday, Oct 10, 2024
GSK plc's shares surged 6.6% to £1,554.23 after announcing a $2.2 billion settlement for 80,000 Zantac lawsuits in the U.S. The agreement resolves 93% of pending cases, potentially stabilizing the company’s future for investors amid litigation uncertainties.